R. Castillo

Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats

Mark B. Anderson, G. Paderes, D. Luthin, 2003, Journal of Pharmacology and Experimental Therapeutics.

Characterization of mono- and diaminopyrimidine derivatives as novel, nonpeptide gonadotropin releasing hormone (GnRH) receptor antagonists.

Mark B. Anderson, G. Paderes, D. Luthin, 2002, Bioorganic & medicinal chemistry letters.

Luteinizing hormone synthesis in cultured fetal human pituitary cells exposed to gonadotropin-releasing hormone.

D. Dumesic, R. Matteri, R. Castillo, 1992, The Journal of clinical endocrinology and metabolism.

Increase in follicle stimulating hormone content occurs in cultured human fetal pituitary cells exposed to gonadotropin-releasing hormone.

W. Bridson, D. Dumesic, R. Castillo, 1991, Life sciences.

Effect of Testosterone Suppression on the Pharmacokinetics of a Potent GnRH Receptor Antagonist

Mark B. Anderson, D. Luthin, K. Anderes, 2002, Pharmaceutical Research.

Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.

Mark B. Anderson, G. Paderes, D. Luthin, 2006, Journal of medicinal chemistry.